Clinical Trial Update: Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx) [Phase 2]

View source ↗

Summary

A Phase 2 trial of clofarabine in myelodysplastic syndrome patients who failed Vidaza was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Clofarabine (clofarabine)

Snippet

Sponsor: Texas Oncology Cancer Center | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: TERMINATED | Results posted: 2013-01-09